Prestige Consumer Healthcare Inc
PBH: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| ?hX | LOCK|P$f> | LOCK|c@Lf&b |
Prestige Earnings: Core Brands Drive Strong 2025 Finish Amid Supply Chain and Tariff Pressure
Narrow-moat Prestige Consumer Healthcare reported strong fourth-quarter results that came in slightly higher than our expectations. Total sales increased 7% year over year to $296.5 million, and adjusted diluted EPS of $1.00 was up from last year’s $0.98. This positive momentum was well received by investors, with shares climbing more than 7% following results. After updating our model and accounting for the time value of money, we are increasing our fair value estimate to $77 per share from $75.
